Login or sign up
For business

ViroLogik GmbH

4.1· 9 reviews
Average ratingGreat
4.1/ 5

Based on 9 reviews

544%
422%
333%
20%
10%
Ask AI

Ask Trustburn about ViroLogik GmbH

Based on 9 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About ViroLogik GmbH

ViroLogik is a biopharmaceutical company which is focusing on innovative drugs for treatment of viral diseases. The focus is on Hepatitis C (HCV). Second indication is HIV- (Human Immunodeficiency Virus, AIDS) infections. ViroLogik is following a novel strategy to prevent formation of drug resistance.

ViroLogik has clinical proof of concept with a proteasome inhibitor in Hepatitis C patients refractory to standard therapy. Formal preclinical development of ViroLogik’s own development candidate VL-01 is progressing.

ViroLogik is following a novel strategy to prevent formation of drug resistance. The approach aims at inhibition of the highly conserved host cell proteasome which is essential for viral replication. This is in contrast to many current drugs which target fast mutating viral proteins and, hence, are prone to induction of drug resistance.

Address
Henkestr. 91